Bookmark

Add to MyYahoo RSS

Bristol-Myers Squibb News

News on Bristol-Myers Squibb continually updated from thousands of sources around the net.

7 hrs ago | Seeking Alpha

Bristol-Myers Squibb: Great Dividend Stocks From The Bond Refugee...

BMY stock is expensive,on a relative basis, to the S&P 500 and healthcare sector earnings multiples and projected five year growth rates.

Comment?

Related Topix: Bloomsbury Publishing, Bristol Myers Squibb, Publishing, Media, Medarex, Pharmaceuticals, Financial Markets, Biotech, Medicine, Healthcare Industry

Tue Apr 22, 2014

Business Wire

Bristol-Myers Squibb and Samsung BioLogics Expand Manufacturing Agreement

Financial terms of the agreement are not disclosed. Bristol-Myers Squibb and Samsung announced their first manufacturing agreement in July 2013 to collaborate in the production of a single commercial antibody cancer drug substance.

Comment?

Related Topix: Biotech, Bristol Myers Squibb, Medicine, Healthcare Industry, Bloomsbury Publishing, Publishing, Media, Medarex, Pharmaceuticals

Mon Apr 21, 2014

The Hartford Courant

Reader Submitted: International Sales Director Appointed

USA beauty distributor/exporter Beauty Enterprises Inc. has appointed Christopher Bueter as international sales director.

Comment?

Related Topix: World News, Kenya, Marketing, Medarex, Sales, Old Saybrook, CT

Tue Apr 15, 2014

Pharmaceutical Online

BMS Files Reyataz-Cobicistat Combo Tablet NDA For HIV-1

Bristol-Myers Squibb announced the filing of a New Drug Application for the fixed-dose combination tablet of atazanavir sulfate with cobicistat for the treatment of patients with HIV-1.

Comment?

Related Topix: HIV/AIDS, Reyataz, Atazanavir Sulfate (generic), Health, Bloomsbury Publishing, Biotech, Bristol Myers Squibb, Publishing, Media, Medicine, Pharmaceuticals, Healthcare Industry

The Motley Fool

Can Merck & Co. Inc. and Bristol-Myers Squibb Co. Dethrone Gilead Sciences Inc. for Hep C Combo?

Does Merck stand a chance? Merck has lagged the hepatitis C race, but the phase 2 results from its oral combination of MK-5172 and MK-8742 in genotype 1 patients are quite impressive.

Comment?

Related Topix: Biotech, Merck , Medicine, Healthcare Industry, Bristol Myers Squibb, Bloomsbury Publishing, Publishing, Media, Medarex, Pharmaceuticals

Reuters

UPDATE 1-Boehringer 2013 profit up on Pradaxa sales, cost cuts

German drugmaker Boehringer Ingelheim's operating income rose 14 percent last year as cost cuts and sales of anti-blood-clotting drug Pradaxa helped counter the impact of currency effects, it said on Tuesday.

Comment?

Related Topix: Bloomsbury Publishing, Biotech, Bristol Myers Squibb, Publishing, Media, Medarex, Medicine, Pharmaceuticals, Healthcare Industry

Sun Apr 13, 2014

Customer Interaction Solutions

Anti-Tumor Drugs Market - Global Industry Analysis, Size, Share,...

Albany, New York, USA April 13, 2014 Tumor is also termed as neoplasm and it is caused by an abnormal proliferation of tissues.

Comment?

Related Topix: Albany, NY, Genetics, Medicine

Sat Apr 12, 2014

MediaPost

Bristol-Myers Squibb, FCB Sue Omnicom, Schulman Over Trade Secrets

A nasty court fight is taking shape in New York between Interpublic's FCB and its client Bristol-Myers Squibb on one side and a former FCB account manager, Stephanie Shulman and Omnicom Group on the other.

Comment?

Related Topix: Omnicom Group, Advertising, DDB Worldwide Communications Group, Bloomsbury Publishing, Biotech, Bristol Myers Squibb, Publishing, Media, Medicine, Pharmaceuticals, Healthcare Industry

Fri Apr 11, 2014

The Toronto Star

Denied experimental drug, cancer patient pins hope on new clinical trial

If that doesn't work, Adrienne Lotton may travel to the U.S. to try a similar drug released for compassionate use.

Comment?

Related Topix: Bloomsbury Publishing, Biotech, Bristol Myers Squibb, Publishing, Media, Medarex, Medicine, Pharmaceuticals, Healthcare Industry

Tue Apr 08, 2014

HIV and Hepatitis

Bristol-Myers Squibb Requests FDA Approval of Daclatasvir and Asunaprevir

Bristol-Myers Squibb has submitted New Drug Applications asking the U.S. Food and Drug Administration to approve its experimental hepatitis C virus NS5A inhibitor daclatasvir and HCV protease inhibitor asunaprevir, the company announced this week.

Comment?

Related Topix: Food and Drug Administration, Biotech, Bristol Myers Squibb, Medicine, Healthcare Industry, Bloomsbury Publishing, Publishing, Media, Medarex, Pharmaceuticals

Contract Pharma Breaking News

DKSH, BMS Extend Asia-Pac Partnership

DKSH , a market expansion services provider with a focus on Asia, has extended its partnership with Bristol-Myers Squibb to provide commercial and distribution services in Asia covering six markets: Hong Kong, Malaysia, Singapore, Taiwan, Thailand and Vietnam.

Comment?

Related Topix: Bloomsbury Publishing, Biotech, Bristol Myers Squibb, Publishing, Media, Medarex, Medicine, Pharmaceuticals, Healthcare Industry, Marketing

Sys-Con Media

European Researchers Invited to Submit Study Proposals for...

Partnering for Cure is Bristol-Myers Squibb's flagship, Pan-European scientific initiative supporting breakthrough research and facilitating greater collaboration and knowledge-sharing with the virology community , Bristol-Myers Squibb invites European researchers to submit innovative research ideas that aim to cure chronic virological diseases.

Comment?

Related Topix: Biotech, Bristol Myers Squibb, Medicine, Healthcare Industry

Mon Apr 07, 2014

Information Technology

Bristol-Myers Squibb Submits NDAs for Daclatasvir and Asunaprevir to...

Bristol-Myers Squibb Company announced today that they have submitted new drug applications with the U.S. Food and Drug Administration for the investigational products daclatasvir , an NS5A replication complex inhibitor, and asunaprevir , a NS3 protease inhibitor.

Comment?

Related Topix: Biotech, Bristol Myers Squibb, Medicine, Healthcare Industry, Bloomsbury Publishing, Publishing, Media, Medarex, Food and Drug Administration, Hepatitis, Health

Seeking Alpha

Bristol-Myers submits NDAs for Hep C drugs

Bristol-Myers Squibb submits new drug applications to the FDA for its NS5A replication complex inhibitor daclatasvir and its NS3 protease inhibitor asunaprevir for the treatment of Hepatitis C. The European Medicines Agency and Japan's Pharmaceutical and Medical Devices Agency are also reviewing the products under accelerated processes.

Comment?

Related Topix: Biotech, Bristol Myers Squibb, Medicine, Healthcare Industry, Bloomsbury Publishing, Publishing, Media, Medarex, Pharmaceuticals, Food and Drug Administration

Tue Apr 01, 2014

Freshnews

Bristol-Myers Squibb to Announce Results for First Quarter 2014 on April 29

Bristol-Myers Squibb Company will announce results for the first quarter of 2014 on Tuesday, April 29, 2014.

Comment?

Related Topix: Biotech, Bristol Myers Squibb, Medicine, Healthcare Industry, Bloomsbury Publishing, Publishing, Media, Medarex, Pharmaceuticals

Thu Mar 27, 2014

Seeking Alpha

A Look Back At Big Pharma Stocks

Four years ago, I wrote about what I called "Big Pharma's Lost Decade" in the stock market.

Comment?

Related Topix: Financial Markets, Bloomsbury Publishing, Biotech, Bristol Myers Squibb, Publishing, Media, Medarex, Medicine, Pharmaceuticals, Healthcare Industry

Examiner.com

Paltrow's 'conscious uncoupling' after 10 years of 'conscious coupling'

Gwyneth Paltrow attends Hollywood Stands Up To Cancer Event with contributors American Cancer Society and Bristol Myers Squibb on 1/28/14.

Comment?

Related Topix: Charitable Organizations, American Cancer Society, Bloomsbury Publishing, Biotech, Bristol Myers Squibb, Publishing, Media, Medarex, Medicine, Pharmaceuticals, Healthcare Industry

The Motley Fool

Big Pharma's Not-So-Hidden Secret to Success

Organic pipeline innovation and acquisitions aside, this has been the biggest driver of Big Pharma's success in recent years.

Comment?

Related Topix: Biotech, Bristol Myers Squibb, Medicine, Healthcare Industry, Bloomsbury Publishing, Publishing, Media, Medarex, Pharmaceuticals, Food and Drug Administration

Wed Mar 26, 2014

Hispanic Business

Five Prime Therapeutics Announces Fourth Quarter and Fiscal 2013 Financial Results

"2013 was a transformational year for Five Prime with many important milestones.

Comment?

Related Topix: Medicine, Cancer, Health, Bloomsbury Publishing, Biotech, Bristol Myers Squibb, Publishing, Media, Medarex, Pharmaceuticals, Healthcare Industry

Independent.ie

Gwyneth Paltrow and Chris Martin escaped to Bahamas before announcing ...

Singer/Songwriter Chris Martin and actress Gwyneth Paltrow attend Hollywood Stands Up To Cancer Event with contributors American Cancer Society and Bristol Myers Squibb hosted by Jim Toth and Reese Witherspoon The former couple confirmed they were ending their marriage of over ten years via a statement on Gwyneth's Goop website on Tuesday.

Comment?

Related Topix: Charitable Organizations, American Cancer Society, Bloomsbury Publishing, Biotech, Bristol Myers Squibb, Publishing, Media, Medarex, Medicine, Pharmaceuticals, Healthcare Industry

•••
•••
•••
•••

Ashburn Jobs

•••
•••
•••
•••
•••